Previous Close | 4.49 |
Open | 4.44 |
Bid | 4.05 x 300 |
Ask | 10.00 x 300 |
Day's Range | 4.37 - 4.48 |
52 Week Range | 2.78 - 7.74 |
Volume | 90,167 |
Avg. Volume | 427,215 |
Market Cap | 201.044M |
Beta | -0.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.24 |
Earnings Date | Aug 7, 2017 - Aug 11, 2017 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.50 |
Verification & Validation“ head-to-head” data exceeds target concordance for blood grouping Overall concordance for antigen typing– 99.8%, demonstrating robustness of the MosaiQ platform Completion of ...
JERSEY, Channel Islands, March 26, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced the retirement of Paul Cowan as its Chairman and Chief Executive Officer. Franz Walt, ...
Understanding how Quotient Limited (NASDAQ:QTNT) is performing as a company requires looking at more than just a years’ earnings. Today I will run you through a basic sense check toRead More...
JERSEY, Channel Islands, March 01, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at ...
JERSEY, Channel Islands, Feb. 20, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced it has entered into definitive agreements for the sale and leaseback of its recently completed ...
JERSEY, Channel Islands, Feb. 20, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of directors effective February 19, 2018. Walt ...
Q3 2018 Quotient Ltd Earnings Call
The Eysins, Jersey-based company said it had a loss of 47 cents per share. The blood test developer posted revenue of $5.9 million in the period. Quotient expects full-year revenue in the range of $24.1 ...
Manufacturing process change implemented with improved assay performance Verification and Validation studies for blood grouping to resume MosaiQ SDS Microarray preparing to enter into formal V&V studies ...
JERSEY, Channel Islands, Jan. 31, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the ...
JERSEY, Channel Islands, Jan. 23, 2018-- Quotient Limited, a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2017, will be released ...
Q4 2017 Quotient Ltd Earnings Call
Leading Quotient Limited (NASDAQ:QTNT) as the CEO, D. J. Paul Cowan took the company to a valuation of USD$196.82M. Understanding how CEOs are incentivised to run and grow their companyRead More...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Quotient Ltd. Here are 5 ETFs with the largest exposure to QTNT-US. Comparing the performance and risk of Quotient Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Quotient Ltd. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Quotient Ltd. – Baxter International Inc. (BAX-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 5.91 million, Net Earnings of USD -21.69 million. Gross ... Read more (Read more...)
The Penicuik, Britain-based company said it had a loss of 58 cents per share. The blood test developer posted revenue of $5.9 million in the period. Quotient expects full-year revenue in the range of $25 ...
Investors are always looking for growth in small-cap stocks like Quotient Limited (NASDAQ:QTNT), with a market cap of USD $174.78M. However, an important fact which most ignore is: how financiallyRead More...